The abstract is read at the publisher; the summary is JClub's.
Engineered Escherichia coli biosynthesizes gadusol up to 4.2 g/l using pathway reprogramming, regulatory tuning, enzyme evolution, and fed-batch fermentation.
- Why it matters: Gadusol’s limited availability restricts sunscreen and antioxidant applications, and microbial production has been hindered by the lack of efficient engineering and rapid quantification.
- What they did: The gadusol pathway was reprogrammed to start at 45.2 mg/l, then a colorimetric high-throughput assay enabled small RNA library screening to reach 700 mg/l. Further directed evolution of transketolase A plus cofactor (NAD+ and adenosylmethionine) optimization increased titer to 965 mg/l, and fed-batch fermentation delivered 4.2 g/l.
- The result: The work establishes a framework combining engineered E. coli and high-throughput measurement to rapidly screen and build gadusol microbial cell factories.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.